Bahiah Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bahiah Meyer has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ashley Uys
Medical Diagnostech (Pty) Ltd, South Africa
1 shared publicationDarryl Uys
Medical Diagnostech (Pty) Ltd, South Africa
1 shared publication- David Andrew Anderson
Burnet Institute, Melbourne, Victoria, Australia
1 shared publication - Fezile Khumalo
Division of Medical Virology, Department of Pathology, University of Cape Town, South Africa
1 shared publication - Jennifer Ann Smit
MatCH Research Unit (MRU), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Witwatersrand, Durban, South Africa
1 shared publication - Jennifer Deese
Global Scientific Affairs, Respiratory Vaccines and Anti-Infectives, Pfizer Inc., New York, New York
1 shared publication
Latest Publications
- Open Access
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A63.1-A63
PA-309 Comparing the accuracy of inflammation detection using the lateral flow point of care Genital InFlammation Test (GIFT) interpreted by visual inspection versus automated reader
Background Sexually transmitted infections (STIs) and bacterial vaginosis (BV) are highly prevalent risk factors for HIV infection, partly driven by genital inflammation. We have developed a novel true point-of-care inflammation lateral flow assay called the Genital InFlammation Test (GIFT). GIFT detects the presence of elevated genital inflammatory cytokines to screen for asymptomatic STIs/BV cases that are missed in settings where syndromic management is practiced. Novel point-of-care tests (like GIFT) must benchmark their performance against the guidelines specified by the WHO’s REASSURED criteria, which includes being equipment-free. This study compared the performance of human eye reading of the GIFT device to an automated device reader. Methods Bio-banked lateral vaginal wall swabs collected from 10 women were tested for the presence of inflammation biomarker bands (IL-1alpha, IL-1beta) on GIFT devices, which were visually assessed by two independent researchers for band intensity (using G-scores between 0–10). Visual inspection of G-score band intensity was benchmarked against cytokine concentrations measured by commercial ELISA. G-score visual assessments were compared with band intensity measurements using an automated device reader (AXXIN-AX-2X-S™). Results Significant concordance was observed between visual (G-scores) for IL-1alpha and IL-1beta and automated reader intensities (rho=0.96, pConclusion This laboratory evaluation of the GIFT device performance, assessed visually or using an automated reader suggests that the reader may offer a sensitivity benefit over visual reading at lower vaginal cytokine concentrations, while accuracy will be comparable at higher concentrations.
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A63.1-A63
Open AccessPA-309 Comparing the accuracy of inflammation detection using the lateral flow point of care Genital InFlammation Test (GIFT) interpreted by visual inspection versus automated reader
Background Sexually transmitted infections (STIs) and bacterial vaginosis (BV) are highly prevalent risk factors for HIV infection, partly driven by genital inflammation. We have developed a novel true point-of-care inflammation lateral flow assay called the Genital InFlammation Test (GIFT). GIFT detects the presence of elevated genital inflammatory cytokines to screen for asymptomatic STIs/BV cases that are missed in settings where syndromic management is practiced. Novel point-of-care tests (like GIFT) must benchmark their performance against the guidelines specified by the WHO’s REASSURED criteria, which includes being equipment-free. This study compared the performance of human eye reading of the GIFT device to an automated device reader. Methods Bio-banked lateral vaginal wall swabs collected from 10 women were tested for the presence of inflammation biomarker bands (IL-1alpha, IL-1beta) on GIFT devices, which were visually assessed by two independent researchers for band intensity (using G-scores between 0–10). Visual inspection of G-score band intensity was benchmarked against cytokine concentrations measured by commercial ELISA. G-score visual assessments were compared with band intensity measurements using an automated device reader (AXXIN-AX-2X-S™). Results Significant concordance was observed between visual (G-scores) for IL-1alpha and IL-1beta and automated reader intensities (rho=0.96, pConclusion This laboratory evaluation of the GIFT device performance, assessed visually or using an automated reader suggests that the reader may offer a sensitivity benefit over visual reading at lower vaginal cytokine concentrations, while accuracy will be comparable at higher concentrations.